The Geriatric Medicines Market report offers perceptive information regarding drivers, restraints, opportunities, and trends of the Geriatric Medicines Market. With the use of historic data from (period), the Geriatric Medicines Market report offers Y-o-Y growth and CAGR until 2026. The insightful data offered in the report makes it an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts and stakeholders that are in search of major industry information in ready-to-access documents with clearly presented tables and graphs.
The global market for Geriatric Medicines Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2020.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The key manufacturers in this market include
- Eli Lilly and Company
- AstraZeneca
- Boehringer Ingelheim
- Abbott Laboratories
- Sanofi
- Bristol-Myers Squibb
- Merck
- Novartis
- Pfizer
- GSK
On the basis of region, the market is divided into:
- North America (U.S. and Canada)
- Latin America (Brazil, Mexico, Argentina, Columbia, and Rest of Latin America)
- Europe (Germany, the U.K., France, Russia, Italy, and Rest of Europe)
- Asia Pacific (China, Japan, South Korea, India, Southeast Asia, and Rest of Asia Pacific)
- Middle East (Saudi Arabia, UAE, Egypt, and Rest of Middle East)
- Africa (North Africa, Central Africa, and South Africa)
By the product type, the market is primarily segmented into
- Analgesics
- Antihypertensives
- Statins
- Antidiabetics
- Proton Pump Inhibitor
- Anticoagulant
- Antipsychotics
- Antidepressants
By the End-user Applications, the market is primarily segmented into
- Cardiovascular diseases
- Arthritis
- Neurological Disorders
- Cancer
- Osteoporosis
- Respiratory
We can also provide the customized separate regional or country-level reports, for the following regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Key Highlights of the Report:
- Growth opportunities in the global Geriatric Medicines Market across major regions during the forecast period.
- Role of emerging markets in the global Geriatric Medicines Market and the scenario during the 2020-2026.
- Technological and product developments that influence growth of the market.
- New trends and advancements in the global Geriatric Medicines Market.
- Insight on various product types and their respective market shares in the overall market.
The report offers you perceptive data of the market and highlights its commercial landscape and pivotal factors that propel and hinder the market growth. It also evaluates production processes, major bottlenecks, and solutions to reduce risks associated with R&D and focuses on major growth strategies adopted by leading market players. The report accurately projects the global market value and regional share during the forecast period
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
- Raw material suppliers
- Distributors/traders/wholesalers/suppliers
- Regulatory bodies, including government agencies and NGO
- Commercial research & development (R&D) institutions
- Importers and exporters
- Government organizations, research organizations, and consulting firms
- Trade associations and industry bodies
- End-use industries
Available Customizations
At Worldwide Market Reports we offer tailored researches to help our clients stay ahead in competition.
Table of Contents
Geriatric Medicines Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Geriatric Medicines
1.1 Geriatric Medicines Market Overview
1.1.1 Geriatric Medicines Product Scope
1.1.2 Market Status and Outlook
1.2 Global Geriatric Medicines Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Geriatric Medicines Market by Type
1.3.1 Global Geriatric Medicines Revenue (Million US$) and Growth Comparison by Type (2014-2025)
1.3.2 Global Geriatric Medicines Revenue Market Share by Type in 2018
1.3.3 Analgesics
1.3.4 Antihypertensives
1.3.5 Statins
1.3.6 Antidiabetics
1.3.7 Proton Pump Inhibitor
1.3.8 Anticoagulant
1.3.9 Antipsychotics
1.3.10 Antidepressants
1.4 Geriatric Medicines Market by End Users/Application
1.4.1 Cardiovascular diseases
1.4.2 Arthritis
1.4.3 Neurological Disorders
1.4.4 Cancer
1.4.5 Osteoporosis
1.4.6 Respiratory
2 Global Geriatric Medicines Competition Analysis by Players
2.1 Global Geriatric Medicines Market Size (Million US$) by Players (2014-2019)
2.2 Competitive Status
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 Mergers & Acquisitions, Expansion Plans
3 Company (Top Players) Profiles and Key Data
3.1 Eli Lilly and Company
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 AstraZeneca
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 Boehringer Ingelheim
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 Abbott Laboratories
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 Sanofi
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 Bristol-Myers Squibb
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 Merck
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 Novartis
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.8.5 Recent Developments
3.9 Pfizer
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.9.5 Recent Developments
3.10 GSK
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Geriatric Medicines Revenue (Value) (2014-2019)
3.10.5 Recent Developments
4 Global Geriatric Medicines Market Size by Type and Application (2014-2019)
4.1 Global Geriatric Medicines Market Size by Type (2014-2019)
4.2 Global Geriatric Medicines Market Size by Application (2014-2019)
4.3 Potential Application of Geriatric Medicines in Future
4.4 Top Consumer/End Users of Geriatric Medicines
5 North America Geriatric Medicines Development Status and Outlook
5.1 North America Geriatric Medicines Market Size (2014-2019)
5.2 North America Geriatric Medicines Market Size and Market Share by Players (2014-2019)
5.3 North America Geriatric Medicines Market Size by Application (2014-2019)
6 Europe Geriatric Medicines Development Status and Outlook
6.1 Europe Geriatric Medicines Market Size (2014-2019)
6.2 Europe Geriatric Medicines Market Size and Market Share by Players (2014-2019)
6.3 Europe Geriatric Medicines Market Size by Application (2014-2019)
7 China Geriatric Medicines Development Status and Outlook
7.1 China Geriatric Medicines Market Size (2014-2019)
7.2 China Geriatric Medicines Market Size and Market Share by Players (2014-2019)
7.3 China Geriatric Medicines Market Size by Application (2014-2019)
8 Rest of Asia Pacific Geriatric Medicines Development Status and Outlook
8.1 Rest of Asia Pacific Geriatric Medicines Market Size (2014-2019)
8.2 Rest of Asia Pacific Geriatric Medicines Market Size and Market Share by Players (2014-2019)
8.3 Rest of Asia Pacific Geriatric Medicines Market Size by Application (2014-2019)
9 Central & South America Geriatric Medicines Development Status and Outlook
9.1 Central & South America Geriatric Medicines Market Size (2014-2019)
9.2 Central & South America Geriatric Medicines Market Size and Market Share by Players (2014-2019)
9.3 Central & South America Geriatric Medicines Market Size by Application (2014-2019)
10 Middle East & Africa Geriatric Medicines Development Status and Outlook
10.1 Middle East & Africa Geriatric Medicines Market Size (2014-2019)
10.2 Middle East & Africa Geriatric Medicines Market Size and Market Share by Players (2014-2019)
10.3 Middle East & Africa Geriatric Medicines Market Size by Application (2014-2019)
11 Market Forecast by Regions and Application (2019-2025)
11.1 Global Geriatric Medicines Market Size by Regions (2019-2025)
11.1.1 North America Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.1.2 Europe Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.1.3 China Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Geriatric Medicines Revenue and Growth Rate (2019-2025)
11.2 Global Geriatric Medicines Market Size by Application (2019-2025)
11.3 The Market Drivers in Future
12 Geriatric Medicines Market Dynamics
12.1 Industry Trends
12.2 Market Drivers
12.3 Market Challenges
12.4 Porters Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
List of Table
List of Tables and Figures
Figure Global Geriatric Medicines Market Size (Million USD) Status and Outlook (2014-2025)
Table Global Geriatric Medicines Market Size (Million USD) and Growth Rate by Regions (2014-2025)
Figure Global Geriatric Medicines Market Share by Regions (2014-2019)
Figure North America Geriatric Medicines Market Size (Million USD) and Growth Rate (2014-2019)
Figure Europe Geriatric Medicines Market Size (Million USD) and Growth Rate (2014-2019)
Figure China Geriatric Medicines Market Size (Million USD) and Growth Rate (2014-2019)
Figure Rest of Asia Pacific Geriatric Medicines Market Size (Million USD) and Growth Rate (2014-2019)
Figure Central & South America Geriatric Medicines Market Size (Million USD) and Growth Rate (2014-2019)
Figure Middle East & Africa Geriatric Medicines Market Size (Million USD) and Growth Rate (2014-2019)
Figure Global Geriatric Medicines Market Share by Type in 2018 & 2025
Figure Analgesics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Antihypertensives Market Size (Million USD) and Growth Rate (2014-2019)
Figure Statins Market Size (Million USD) and Growth Rate (2014-2019)
Figure Antidiabetics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Proton Pump Inhibitor Market Size (Million USD) and Growth Rate (2014-2019)
Figure Anticoagulant Market Size (Million USD) and Growth Rate (2014-2019)
Figure Antipsychotics Market Size (Million USD) and Growth Rate (2014-2019)
Figure Antidepressants Market Size (Million USD) and Growth Rate (2014-2019)
Table Global Geriatric Medicines Market Size (Million US$) Comparison by Application (2014-2025)
Figure Global Geriatric Medicines Market Share by Application in 2018 & 2025
Figure Geriatric Medicines Market Size (Million USD) and Growth Rate in Cardiovascular diseases (2014-2019)
Figure Geriatric Medicines Market Size (Million USD) and Growth Rate in Arthritis (2014-2019)
Figure Geriatric Medicines Market Size (Million USD) and Growth Rate in Neurological Disorders (2014-2019)
Figure Geriatric Medicines Market Size (Million USD) and Growth Rate in Cancer (2014-2019)
Figure Geriatric Medicines Market Size (Million USD) and Growth Rate in Osteoporosis (2014-2019)
Figure Geriatric Medicines Market Size (Million USD) and Growth Rate in Respiratory (2014-2019)
Table Global Geriatric Medicines Revenue (Million US$) by Players (2014-2019)
Table Global Geriatric Medicines Revenue Market Share by Players (2014-2019)
Eigure Geriatric Medicines Market Size Share by Players in 2018
Table Global Geriatric Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Global Top 5 Players Geriatric Medicines Market Share in 2018
Figure Global Top 10 Players Geriatric Medicines Market Share in 2018
Table Geriatric Medicines Key Players Product/Service
Table Mergers & Acquisitions, Expansion Plans
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Description and Business Overview
Table Eli Lilly and Company Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Eli Lilly and Company (2014-2019)
Table Eli Lilly and Company Geriatric Medicines Recent Developments
Table AstraZeneca Basic Information List
Table AstraZeneca Description and Business Overview
Table AstraZeneca Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of AstraZeneca (2014-2019)
Table AstraZeneca Geriatric Medicines Recent Developments
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Description and Business Overview
Table Boehringer Ingelheim Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Boehringer Ingelheim (2014-2019)
Table Boehringer Ingelheim Geriatric Medicines Recent Developments
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Description and Business Overview
Table Abbott Laboratories Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Abbott Laboratories (2014-2019)
Table Abbott Laboratories Geriatric Medicines Recent Developments
Table Sanofi Basic Information List
Table Sanofi Description and Business Overview
Table Sanofi Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Sanofi (2014-2019)
Table Sanofi Geriatric Medicines Recent Developments
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Description and Business Overview
Table Bristol-Myers Squibb Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Bristol-Myers Squibb (2014-2019)
Table Bristol-Myers Squibb Geriatric Medicines Recent Developments
Table Merck Basic Information List
Table Merck Description and Business Overview
Table Merck Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Merck (2014-2019)
Table Merck Geriatric Medicines Recent Developments
Table Novartis Basic Information List
Table Novartis Description and Business Overview
Table Novartis Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Novartis (2014-2019)
Table Novartis Geriatric Medicines Recent Developments
Table Pfizer Basic Information List
Table Pfizer Description and Business Overview
Table Pfizer Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of Pfizer (2014-2019)
Table Pfizer Geriatric Medicines Recent Developments
Table GSK Basic Information List
Table GSK Description and Business Overview
Table GSK Geriatric Medicines Products, Services and Solutions
Table Revenue (Million US$) in Geriatric Medicines Business of GSK (2014-2019)
Table GSK Geriatric Medicines Recent Developments
Table Global Geriatric Medicines Market Size by Type (2014-2019) (Million US$)
Figure Global Geriatric Medicines Revenue Market Share by Type in 2018
Table Global Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Figure Global Geriatric Medicines Revenue Market by Application in 2018
Table Top Consumer/End Users of Geriatric Medicines
Figure North America Geriatric Medicines Market Size and Growth Rate(2014-2019) (Million USD)
Table North America Geriatric Medicines Market Size by Players (2014-2019)(Million US$)
Figure North America Geriatric Medicines Market Size Share by Players in 2018
Table North America Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Figure North America Geriatric Medicines Revenue Market Share by Application (2014-2019)
Figure North America Geriatric Medicines Market Size Share by Application in 2018
Figure Europe Geriatric Medicines Market Size and Growth Rate(2014-2019) (Million USD)
Table Europe Geriatric Medicines Market Size by Players (2014-2019)(Million US$)
Figure Europe Geriatric Medicines Market Size Share by Players in 2018
Table Europe Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Figure Europe Geriatric Medicines Revenue Market Share by Application (2014-2019)
Figure Europe Geriatric Medicines Market Size Share by Application in 2018
Figure China Geriatric Medicines Market Size and Growth Rate(2014-2019) (Million USD)
Table China Geriatric Medicines Market Size by Players (2014-2019)(Million US$)
Figure China Geriatric Medicines Market Size Share by Players in 2018
Table China Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Figure China Geriatric Medicines Revenue Market Share by Application (2014-2019)
Figure China Geriatric Medicines Market Size Share by Application in 2018
Figure Rest of Asia Pacific Geriatric Medicines Market Size and Growth Rate(2014-2019) (Million USD)
Table Rest of Asia Pacific Geriatric Medicines Market Size by Players (2014-2019)(Million US$)
Figure Rest of Asia Pacific Geriatric Medicines Market Size Share by Players in 2018
Table Rest of Asia Pacific Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Figure Rest of Asia Pacific Geriatric Medicines Revenue Market Share by Application (2014-2019)
Figure Rest of Asia Pacific Geriatric Medicines Market Size Share by Application in 2018
Figure Central & South America Geriatric Medicines Market Size and Growth Rate(2014-2019) (Million USD)
Table Central & South America Geriatric Medicines Market Size by Players (2014-2019)(Million US$)
Figure Central & South America Geriatric Medicines Market Size Share by Players in 2018
Table Central & South America Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Figure Central & South America Geriatric Medicines Revenue Market Share by Application (2014-2019)
Figure Central & South America Geriatric Medicines Market Size Share by Application in 2018
Figure Middle East & Africa Geriatric Medicines Market Size and Growth Rate(2014-2019) (Million USD)
Table Middle East & Africa Geriatric Medicines Market Size by Players (2014-2019)(Million US$)
Figure Middle East & Africa Geriatric Medicines Market Size Share by Players in 2018
Table Middle East & Africa Geriatric Medicines Market Size by Application (2014-2019) (Million US$)
Figure Middle East & Africa Geriatric Medicines Revenue Market Share by Application (2014-2019)
Figure Middle East & Africa Geriatric Medicines Market Size Share by Application in 2018
Figure Global Geriatric Medicines Market Size and Growth Rate (Value) (2019-2025) (Million US$)
Table Global Geriatric Medicines Market Size by Regions (2019-2025) (Million US$)
Figure Global Geriatric Medicines Market Size Share by Regions (2019-2025)
Figure Global Geriatric Medicines Market Size Share by Regions in 2025
Figure North America Geriatric Medicines Revenue (Million USD) and Growth Rate (2019-2025)
Figure Europe Geriatric Medicines Revenue (Million USD) and Growth Rate (2019-2025)
Figure China Geriatric Medicines Revenue (Million USD) and Growth Rate (2019-2025)
Figure Rest of Asia Pacific Geriatric Medicines Revenue (Million USD) and Growth Rate (2019-2025)
Figure Central & South America Geriatric Medicines Revenue (Million USD) and Growth Rate (2019-2025)
Figure Middle East & Africa Geriatric Medicines Revenue (Million USD) and Growth Rate (2019-2025)
Table Global Geriatric Medicines Market Size by Application (2019-2025) (Million USD)
Figure Global Geriatric Medicines Market Size by Application (2019-2025)
Figure Global Geriatric Medicines Market Size by Application in 2025
Table Global Geriatric Medicines Market Size by Type (2019-2025) (Million US$)
Figure Global Geriatric Medicines Market Size by Type (2019-2025)
Figure Global Geriatric Medicines Market Size by Type in 2025
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure Porter's Five Forces Analysis
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Asia Pacific digital health and wellness market will grow by 20.8% annually with a total addressable market cap of $3,072.0 billion over 2024-2033. The growth is driven by an increasing number of chronic diseases, the growing investment in health and wellness programs, the increased use of smartphon...
Europe digital health and wellness market was valued at $100.9 billion in 2023 and will grow by 18.9% annually over 2023-2033. The growth is driven by an increasing number of chronic diseases, the growing investment in health and wellness programs, the increased use of smartphones and wearable devic...
North America digital health and wellness market is projected to grow by 18.6% annually in the forecast period and reach $658.3 billion by 2033. The growth is driven by an increasing number of chronic diseases, the growing investment in health and wellness programs, the increased use of smartphones ...
Global digital health and wellness market will reach $2,084.6 billion by 2033, growing by 19.2% annually over 2023-2033. The growth is driven by an increasing number of chronic diseases, the growing investment in health and wellness programs, the increased use of smartphones and wearable devices, an...
The Geriatric Healthcare Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manuf...
Overview of the Global Geriatric Living Enhancements Market:
The report discusses everything a marketer requires before investing in the global Geriatric Living Enhancements Market during the forecast period 2023-20...
Overview of the Global Geriatric Nursing Care Services Market:
The report discusses everything a marketer requires before investing in the global Geriatric Nursing Care Services Market during the forecast period 202...
The global OTC Cold and Cough Medicines market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players...
Overview of the Global Veterinary Medicines Retail Sales Market:
The report discusses everything a marketer requires before investing in the global Veterinary Medicines Retail Sales Market during the forecast period...
Overview of the Global Prescription Veterinary Medicines Retail Sales Market:
The report discusses everything a marketer requires before investing in the global Prescription Veterinary Medicines Retail Sales Market ...